Advyzon Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Advyzon Investment Management's VRTX Position: Q2 2026 in Review
Advyzon Investment Management increased its Vertex Pharmaceuticals (VRTX) stake by 25% in Q2 2026, buying an estimated $155K and bringing the position to 1,740 shares worth $864K. The position accounts for 0.06% of the portfolio, ranked #296.
Advyzon Investment Management first reported a position in VRTX in Q1 2025 and has held it in 4 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Advyzon Investment Management held 1,740 shares of Vertex Pharmaceuticals worth $864K as of Q2 2026.
- Advyzon Investment Management bought 349 Vertex Pharmaceuticals shares in Q2 2026, an estimated $155K.
- Vertex Pharmaceuticals made up 0.06% of Advyzon Investment Management's portfolio in Q2 2026, its #296 holding.
- Advyzon Investment Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Advyzon Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.